ADAM17 and hypopharynx cancer: The results showed that, according to gene microarray analysis, ADAM10 was not increased in hypopharyngeal cancer compared to normal tissue[64] and that both ADAM10 and ADAM17 were not presented in the list of genes with significantly altered expression levels in pharyngolaryngeal cancer compared to normal tissue.